Immortals review

If you are taking a low dose for metabolic reasons rather than weight, this is the clearest framing of that here — GLP-1s presented as a metabolic intervention rather than a weight-loss one, which is the frame most people who microdose actually arrive in — and it backs that with unlimited physician follow-up, no membership fee, and a stated HSA/FSA path. "Microdose" is offered openly as a dosage type at intake rather than being something you have to talk a clinician into. The structural problem is that choosing it changes nothing about the bill: it is the same product at the same from-price, so a fraction of the drug costs what a personalized full dose does. And the only term published is a quarterly one, three months paid up front, so the smallest way to try it is a season rather than a month.

Vs median

$27/mo above the $169 median across the 261 of 407 programs here that publish a plain monthly rate

Market

$59–$1,300/mo is the full published spread on this site

Structure

Same price at every dose

Consult

Included in the price

Dietitian

Not included

Labs

Not required

Pricing

Flat at every dose

Immortals does not publicly identify the pharmacy that fills its prescriptions. No bloodwork is required before you start. A clinician review is included in the price.

Bryan Johnson's longevity telehealth arm, selling compounded semaglutide bundled with glycine and B12 and framing GLP-1s as a longevity intervention rather than a weight-loss one — which is the frame most microdosers actually arrive in. Physicians are licensed in your state, follow-up messaging is unlimited for up to twelve months, there is no membership fee, and intake-to-door runs three to seven days. For a low-dose reader the structural problem is plain: "Microdose" is offered as a dosage type inside the same product at the same from-price, so choosing to take less does not reduce what you pay, and there is no monthly option to leave from.

Choosing the microdose does not lower the price — it is a dosage type inside the same product at the same from-price, so a fraction of the drug costs what a personalized full dose does

• Compounded GLP-1s are not FDA-approved, and intentional microdosing is off-label and unproven
• There is no month-to-month option: the published rate is billed quarterly with three months paid up front, so the smallest commitment is a quarter
• Semaglutide only in the GLP-1 line we could price, and injectable only — no tirzepatide microdose and no needle-free route
• The dispensing pharmacies are described only as licensed U.S. pharmacies and are never named

Immortals is one of 407 low-dose GLP-1 programs compared on this site, and 261 of them publish a monthly rate you can read before signing up. The full list puts every published price in one place, with the companies that pay us listed first — something we state there, on the page it applies to.

Intentional GLP-1 microdosing is off-label and unproven — no randomized trial has established that a sub-label dose does anything, and any dose belongs with a clinician who knows your history. If you are going to have that conversation, have it with real numbers.

• What the evidence actually shows
• Microdosing semaglutide
• Low dose vs full dose
• Microdose & reconstitution calculator
• Titration planner